Atlas Trials

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Clinical trial NCT01002092 · UNKNOWN

Trial details

NCT number
NCT01002092
Sponsor
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Osteosarcoma
Start date
2009-02-01
Primary completion
2014-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.